Måndag 3 November | 07:34:59 Europe / Stockholm

Prenumeration

2025-10-20 14:30:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 6 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)Q3 2025E
Net sales185
Organic growth in local currency (%)-0.30
Gross profit138
EBITDA30.4
EBIT12.6
Net profit9.56
Earnings per share (SEK)0.31

XVIVO Perfusion’s Q3 report will be released on Thursday 23 October at 07.30 CEST.